Letters to the Editor

• ORBITA Correctly Positioned in 2019 ESC CCS Guidelines The Task Force chairmen for the latest ESC guideline on CCS take issue with a commentary by John Mandrola, MD, and stand by their decision regarding the infamous sham PCI trial in stable CAD.
  Letters to the Editor, September 2019
• Making Patients With Obesity the Enemy Is Never Acceptable Obesity is a complex, chronic disease that should not be characterized in a dismissive fashion by medical professionals, experts caution.
  Letters to the Editor, February 2019
• Lessons Learned From Mandatory Cardiac Screening of Young Athletes The authors of a UK study on athletic screening of young male soccer players see value in the enterprise.
  Letters to the Editor, November 2018
• Why Donald Trump Is Better Off Knowing His Calcium Score A trio of preventive cardiologists take issue with a commentary questioning the utility of coronary calcium scores.
  Letters to the Editor, March 2018
• AMA Reacts to Article About Relevance of Organized Medicine Dr David Barbe, president of the AMA, discusses the organization's recent activities.
  Letters to the Editor, August 2017
• Beta-Blocker Side Effects and Brain Trickery Reconsidered Drs Messerli and Bangalore respectfully disagree with Dr John Mandrola's recent commentary on the role of the nocebo effect in patient perceptions of drug side effects.
  Letters to the Editor, June 2017
• In Defense of Left Atrial Appendage Closure The lead author of a paper on the US clinical experience with the Watchman left atrial appendage closure device post-FDA approval responds to a critical column by Dr John Mandrola.
  Letters to the Editor, November 2016
• Paul Offit Responds to News About HPV Vaccine 'Syndrome' A vaccine expert points out the dangers in ignoring large-scale safety studies on the HPV vaccine while focusing on anecdotal case reports.
  Letters to the Editor, August 2016
• AANP Responds to VA Plan for Independent Advanced Practice RNs The president of the American Association of Nurse Practitioners responds to a proposal that would give veterans direct access to advanced practice in US veterans' facilities without physician oversight.
  Letters to the Editor, July 2016
• Response to 'Cure for Mantle Cell Lymphoma Within Reach' Researchers not involved in the current research contest the characterization of bendamustine and rituximab as a "salvage" therapy, among other concerns.
  Letters to the Editor, June 2016
• Rebuttal of 'Doubting the BELIEF Trial' by John Mandrola The editor of a website for patients with atrial fibrillation and the trial investigators critique a 'Trials and Fibrillations' column by Dr John Mandrola.
  Letters to the Editor, November 2015
• ASAM Responds to 'Physician Health Programs: More Harm Than Good?' The American Society of Addiction Medicine objects to a Medscape news article that examines the current role of physician health programs.
  Letters to the Editor, September 2015
• FSPHP Response to 'Physician Health Programs: More Harm Than Good?' Doris C. Gundersen, MD, president of the Federation of State Physician Health Programs, responds to a Medscape news article on growing scrutiny of physician health programs.
  Letters to the Editor, September 2015
• Letter to the Editor: 340B Program Safety Net Hospitals for Pharmaceutical Access (SNHPA), an advocacy organization for 340B providers, responds to a recent Medscape article on the program.
  Letters to the Editor, January 2015
• Responses to 'Briakinumab More Effective Than Methotrexate in Psoriasis' A reader and a source quoted in the article point out an error in the use of the term "ghostwriter."
  Letters to the Editor, November 2011
• SNPs Used in Smoking Cessation Study Are Public Info, Author Says A study author writes a letter to the editor to correct a potential false impression that the basis of the genotype score used in his study was not publicly disclosed.
  Letters to the Editor, September 2010